#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Andersen-Tawil syndrome Propionic acidaemia Acquired C1 inhibitor deficiency Thalassaemia Craniopharyngioma Atopic keratoconjunctivitis B-cell lymphoma Extra-osseous Ewing's sarcoma Uterine leiomyosarcoma Cerebral arteriovenous malformation haemorrhagic Nodal marginal zone B-cell lymphoma Hypoxic-ischaemic encephalopathy Gestational trophoblastic tumour Sickle cell disease Waldenstrom's macroglobulinaemia recurrent More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy Factor VIII deficiency – Trials in Disease Richter’s syndrome – Diagnostics Mastocytosis – Trials in Disease Chondrosarcoma – Basic Information Cystic fibrosis lung – Diagnostics Netherton’s syndrome – Treatment Alveolar rhabdomyosarcoma – Basic Information Proteus syndrome – Diagnostics Basal cell naevus syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Promethazine Hydrochloride GVV858 Mometasone Cocarboxylase Tetrahydrate Fingolimod Axitinib REGN7999 Levofloxacin Hemihydrate Losartan Opevesostat Tosilate Cipaglucosidase Alfa Levonorgestrel Psilocybine Prs-344 Gallium (68Ga) Chloride Lixisenatide Esketamine Protease Allopurinol Ifezuntirgene Inilparvovec More therapies…

    Learn about Your Condition

    Partial seizures Right ventricular dysfunction Myocarditis Oxygen therapy Decreased appetite Anaemia Immunodeficiency Implantation complication Mantle cell lymphoma stage IV Thrombocytosis Follicular lymphoma Ewing's sarcoma metastatic Death neonatal Acquired ATTR amyloidosis Eye disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypophosphatasia

  • A Study Testing the Safety and Tolerability of ALE1 in Healthy Adults and Adults with Hypophosphatasia

    Not yet recruiting

    2 1
    Investigated Drugs:
    • ALE1
    Germany

  • Study of ALXN1850 for Children Aged 2 to 12 with Hypophosphatasia Who Have Not Previously Received Asfotase Alfa Treatment

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Alxn1850
    Belgium Finland France Italy Poland Romania +2

  • Study on ALXN1850 and Asfotase Alfa for Children Aged 2-12 with Hypophosphatasia Previously Treated with Asfotase Alfa

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Alxn1850
    • Asfotase Alfa
    France Germany Italy

  • Study of ilofotase alfa effects on biomarkers in adults with hypophosphatasia

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Ilofotase Alfa
    Germany

  • Study on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Alxn1850
    Austria Belgium France Germany Italy Poland +2

  • Study on Immunosuppressive Therapies with Asfotase Alfa for Patients with Hypophosphatasia Experiencing Reduced Treatment Effectiveness

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Asfotase Alfa
    • Bortezomib
    • Methotrexate Disodium
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!